To evaluate the mechanism of the promoting effect of goitrogens on thyroid tumorigenesis, well-known goitrogens having different pharmacologic action, i.e., thiourea, phenobarbital sodium (PB), potassium thi-ocyanate (KSCN), and 3,4,5,6-tctrachloro-2',4',5',7'-tetraiodo-fluorescein sodium salt (Rose Bengal B, FD&C Red No. 105) (FR105) were administered to the DHPN-initiated and non-initiated F344 male rats in the drinking water for 25 weeks. Remington's iodine deficient diet (I-dcf) was fed as a positive control. These goitrogens showed significant tumor promoting effect or promoting tendency on the rat thyroids. According to the changes in thyroid morphology and thyroid-related hormone tilers observed in the present study, we proposed to classify goitrogens at least into 2 groups, i.e., iodine deficiency-type promoters and the iodine excess-type promoters. The former contains goitrogens inducing TSH-stimulated diffuse goiter composed of uniform follicles with activated tall follicular epithelial cells, such as thiourea, KSCN and PB, and the latter contains goitrogens inducing colloid goiter composed of a mixture of colloid-rich follicles with flat follicular cells and normal-looking follicles with cuboidal follicular cells, such as FR105. This classification may be useful for the risk assessment of goitrogens.
1. Abrams GM and Larsen PR (1973). Triiodothyro-nine and thyroxine in the serum and thyroid gland of iodine-deficient ratsJ Clin. Invest.52: 2522–2531.
2.
2. Andersen CJ, Kciding NR, and Nielsen AB (1964). False elevation of serum protein-bound-iodine caused by red colored drugs or foods.Scand. J. Clin. Lab. Invest.16: 249.
3.
3. Axelrad AA and Leblond CP (1955). Induction of thyroid tumors in rats by a low iodine diet.Cancer8: 339–367.
4.
4. Beaumont A and Fragu P (1985). Ultrastructural changes in the rat thyroid gland during iodine deficiency.Biol. Cell54: 177–180.
5.
5. Bernstein R, Haugen HF, and Frcy H (1975). Thyroid function during erythrosine ingestion in doses encountered in therapy with conventional antibiotics.Scand. J. Clin. Lab. Invest.35: 49–52.
6.
6. Chen KTC and Rosai J (1977). Follicular variant of thyroid papillary carcinoma of the thyroid: A clini-copathologic study of six cases.Am. J. Surg. Pathol.1: 124–130.
7.
7. Collins TFX and Long EL (1976). Effects of chronic oral administration of erythrosine in the Mongolian gerbil.Fd. Cosmet. Toxicol.14: 233–248.
8.
8. Correa P and Welsh RA (1960). The effect of excess iodine intake on the thyroid gland of the rat.Arch. Pathol.70: 247–251.
9.
9. Denef J-F, Haumont S, Cornette C, and Beckers C (1981). Correlated functional and morphomctric study of thyroid hyperplasia induced by iodine deficiency.Endocrinology108: 2352–2358.
10.
10. Emerson CH, Liberman C, and Braverman LE (1987). Hypothyroidism. In: The Thyroid, WL Green (ed), Current Endocrinology: Basic and Clinical Aspects, LV Avioli (Series Chief ed). Elsevier, New York, pp. 219–270.
11.
11. Follis RH Jr (1959). Experimental colloid goiter in the hamster.Proc. Soc. Exper. Biol. Med.100: 203–206.
12.
12. Gardner DF, Utiger RD, Schwarts SL, Witorsch P, Meyers B, Braverman LE, and Witorsch RJ (1987). Effects of oral erythrosine (2',4',5'.7'-tetraiodoflu-orescein) on thyroid function in normal men.Toxicol. Appl. Pharmacol.91: 299–304.
13.
13. Gershengorn MC and Robbins J (1987). Thyroid neo-plasia. In: The Thyroid, WL Green (ed), Current En docrinology: Basic and Clinical Aspects, LV Avioli (Series Chief ed). Elsevier, New York, pp. 293–338.
14.
14. Green WL (1978). Mechanisms of action of antithy-roid compounds. In: The Thyroid: A fundamental and clinical text, 4th ed., SC Werner and SH Ingbar (eds). Harper and Row, Hagerstown, Md., pp. 77–87.
15.
15. Green WL (1987). Physiology of the thyroid gland and its hormone. In: The Thyroid, WL Green (ed), Current Endocrinology: Basic and Clinical Aspects, LV Avioli (Series Chief ed). Elsevier, New York, pp. 1–46.
16.
16. Hansen WH, Zwickey RE, Brouwer JB, and Fitzhugh OG (1973). Long-term toxicity studies of erythrosine. I. Effects in rats and dogs.Fd. Cosmet. Toxicol.11: 527–534.
17.
17. Haran-Ghera N, Pullar P, and Furth J (1960). Induction of thyrotropin-dependent thyroid tumors by thyrotropes.Endocrinology66: 694–701.
18.
18. Harvey SC (1975). Hypnotics and sedatives. The barbiturates. In: The Pharmacological Basis of Therapeutics, 5th ed.LS Goodman and A Gilman (eds). MacMillan Publishing Co., Inc., New York, pp. 124–136.
19.
19. Hedinger C, Williams ED, and Sobin LH (1988). His-tologic typing of the thyroid tumours. In: International Histological Classification of Tumours, 2nd ed.WHO, Springer-Verlag, Berlin.
20.
20. Hershman JM and Van Middlesworth L (1962). Effect of antithyroid compounds on the deiodination of thyroxine in the rat.Endocrinology71: 94–97.
21.
21. Hiasa Y, Ohshima M, Kitahori Y, Konishi N, Shimoyama T, Sakaguchi Y, Hashimoto H, Minami S, and Kato Y (1988). The promoting effects of food dye, erythrosine (Red 3) and Rose Bengal B (Red 105), on thyroid tumors in partially thyroidectomized N-bis(2-hydroxypropyl)nitrosamine-trcated rats.Jpn. J. Cancer Res.79: 314–319.
22.
22. Ito A, Watanabe H, Naito M, Aoyama H, Nakagawa Y, and Fujimoto N (1986). Induction of thyroid tumors in (C57BL/6N X C3H/N)F1 mice by oral administration of 9–3',4',5',6'-tetrachloro-o-car-boxyphenyl-6-hydroxy-2,4,5,7-tetraiodo-3-isoxan-thone sodium (Food Red 105, Rose Bengal B).J. Natl. Cancer Inst.77: 277–281.
23.
23. Maekawa A, Kurokawa Y, Takahashi M, Kokubo T, Ogiu T, Onodera H, Tanigawa H, Ohno Y, Furukawa F, and Hayashi Y (1983). Spontaneous tumors in F344/DuCrj rats.Jpn. J. Cancer Res.74: 365–372.
24.
24. McClain RM, Posch RC, Bosakowski T, and Armstrong JM (1988). Studies on the mode of action of thyroid gland tumor promotion in rats by phenobar-bital.Toxicol. Appl. Pharmacol.94: 254–265.
25.
25. Melmed S, Nademonee K, Reed AW, Hendrickson J, Singh BN, and Hershman JM (1981). Hyperthy-roxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration.J. Clin. Endocrinol. Metab.53: 997–1001.
26.
26. Ohshima M and Ward JM (1984). Promotion of N-methyl-N-nitrosourea-induced thyroid tumors by iodine deficiency in F344/NCr rats.J. Natl. Cancer Inst.73: 289–296.
27.
27. Pisarev MA, Cardinali DP, Juvenal GJ, Boado RJ, Barontini M, and Vacas MI (1983). Ipsilateral thyroid growth and depressed thyroid hormone synthesis and content after unilateral superior cervical glangionec-tomy in rats.Acta. Physiol. Latinoam.33: 165–170.
28.
28. Purves HD and Griesbach WE (1947). Studies on experimental goitre. VIII. Thyroid tumours in rats treated with thiourea.Br. J. Exp. Pathol.28: 170–179.
29.
29. Remington RE (1937). Improved growth in rats on iodine deficient diet.J. Nutrition13: 223–233.
30.
30. Riesco G, Taurog A, Larsen PR, and Krulich L, (1977). Acute and chronic response to iodine deficiency in rats.Endocrinology100: 303–313.
31.
31. Ruiz M and Ingbar SH (1983). Effect of erythrosine (2',4',5',7'-tetraiodofluorescein) on the metabolism of thyroxine in rat liver.Endocrinology110: 1613–1617.
32.
32. Sakamoto A, Kasai N, and Sugano H (1983). Poorly differentiated carcinoma of the thyroid. A clinico-pathologic entity for a high-risk group of papillary and follicular carcinoma.Cancer52: 1849–1855.
33.
33. Savoie JC, Massin JP, Thomopoulos P, and Leger F (1975). Iodine-induced thyrotoxicosis in apparently normal thyroid glands.J. Clin. Endocrinol. Metab.41: 685–691.
34.
34. Scranton JR, Nissen WM, and Halmi NS (1969). The kinetics of the inhibition of thyroidal iodine accumulation by thiocyanate: A re-examination.Endocrinology85: 603–607.
35.
35. The 30th Meeting of the Joint FAO/WHO Expert Committee on Food Additives, Rome, 2–11 June 1986 (1987). Erythrosine. In: Toxicological Evaluation of Certain Food Additives and Contaminants, WHO Food Additive Series: 21. Cambridge University Press, Cambridge, pp. 81–109.
36.
36. Van Middlesworth L (1985). Thiocyanate feeding with low iodine diet causes chronic iodine retention in thyroids of mice.Endocrinology116: 665–670.
37.
37. Vought RL, Brown FA, and Wolff J (1972). Erythrosine: An adventitious source of iodide.J. Clin. Endocrinol. Metab.34: 747–752.
38.
38. Wolff J (1964). Transport of iodide and other anions in the thyroid gland.Physiol. Rev.44: 45–90.
39.
39. Wolff J (1969). Iodide goiter and the pharmacologic effects of excess iodide.Am. J. Med.47: 101–124.
40.
40. Wolff J, Chaikoff IL, Taurog A, and Rubin L (1946). The disturbance in iodine metabolism produced by thiocyanate: The mechanism of its goitrogenic action with radioactive iodine as indicator.Endocrinology39: 140–148.
41.
41. Zeligs JD and Wollman SH (1977). Ultrastructure of blebbing and phagocytosis of blebs by hyperplastic thyroid epithelial cells in vivo.J. Cell Biol.72: 584–594.
